The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

[CINP2024] Symposia

CINP2024 » Symposia

Symposium 20
Dysfunction of Glutamate, Dopamine, and GABA Neurotransmission in Schizophrenia: Integrative View for Pathophysiologic Analysis and Innovative Treatment

Sun. May 26, 2024 10:45 AM - 12:00 PM Room 1 (Hall C)

Chair: Toru Nishikawa (Showa Medical University/Kyoto Prefectural University of Medicine)

[IS20-3] Neurocognition and NMDAR Co-agonists Pathways in Individuals with Treatment Resistant First-Episode Psychosis

*Kim Q. Do1, Sara Camporesi1,2, Lijing Xin3, Philippe Golay2, Chin Bin Eap1,4, Martine Cleusix1, Michel Cuenod1, Margot Fournier1, Kenji Hashimoto5, Raoul Jenni1, Julie Ramain2, Romeo Restellini2,6, Alessandra Solida2,7, Philippe Conus2, Ines Khadimallah1 (1. Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland, 2. Service of General Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland, 3. Center for Biomedical Imaging, Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland, 4. School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland, 5. Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan, 6. Emergency Medicine Department, Geneva University Hospital, Geneva, Switzerland , 7. Psychiatry Department for Adults 2, Neuchâtel Centre of Psychiatry, Prefargier, Switzerland)

Keywords:Treatment-resistant schizophrenia, D-serine, Cognition, NMDAR, First-episode psychosis

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password